Outcome of transvaginal pelvic reconstructive surgery with Prolift after a median of 2 years' follow-up.
OBJECTIVE
This study seeks to analyze the medium- to long-term outcome of transvaginal pelvic reconstructive surgery using the Prolift™ system for pelvic organ prolapse.


METHODS
Sixty-five patients who underwent pelvic floor reconstruction using Prolift™ were followed for 1 to 3 years postoperatively. Assessment included pre- and postoperative Pelvic Organ Prolapse Quantification (POP-Q) stage, Urogenital Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7) scores.


RESULTS
The overall anatomic success rate was 97% after a median of 24.5 months and 94% for the 34 women followed for more than 2 years. POP-Q stage, UDI-6, and IIQ-7 scores all improved significantly after surgery. Complications included one bladder perforation (1.5%) and one bowel perforation (1.5%), prolonged catheterization in four patients (6%), and mesh erosion in one (2%). Eight received blood transfusion (12%).


CONCLUSIONS
Prolift™ surgery yielded a good anatomical outcome and satisfactory symptom improvement that appeared to be durable after 2 years.
Huang
Wen-Chu
WC
Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, 10449, Taiwan.
Lin
Tzu-Yin
TY
Lau
Hui-Hsuan
HH
Chen
Shwu-Shiuang
SS
Hsieh
Ching-Hung
CH
Su
Tsung-Hsien
TH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D056887:Pelvic Organ Prolapse / Q000601:surgery*; D012189:Retrospective Studies; D053825:Suburethral Slings; D013526:Surgical Mesh; D016896:Treatment Outcome
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Feb;17(2):195-201
15915320
J Formos Med Assoc. 2005 Apr;104(4):249-53
15909062
Obstet Gynecol. 1997 Apr;89(4):501-6
9083302
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Sep;18(9):1059-64
17219252
BJOG. 2004 Aug;111(8):831-6
15270932
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Mar;19(3):437-40
17896064
Curr Opin Urol. 2008 Jul;18(4):377-82
18520758
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Apr;18(4):397-400
16804634
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jul;18(7):743-52
17131170
BJOG. 2008 Jan;115(1):22-30
18053100
Am J Obstet Gynecol. 2008 Dec;199(6):694.e1-6
18986641
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Mar;18(3):251-6
16699914
Curr Opin Obstet Gynecol. 2006 Oct;18(5):560-6
16932053
Am J Obstet Gynecol. 1996 Dec;175(6):1418-21; discussion 1421-2
8987919
Obstet Gynecol. 2009 Sep;114(3):600-609
19701041
Eur J Obstet Gynecol Reprod Biol. 2004 Jul 15;115(1):90-4
15223172
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
8694033
J Sex Med. 2009 Nov;6(11):3201-7
19627464
Am J Obstet Gynecol. 2004 Nov;191(5):1533-8
15547521
Curr Opin Obstet Gynecol. 2002 Oct;14(5):527-35
12401983
Obstet Gynecol. 2007 Feb;109(2 Pt 1):303-8
17267828
Curr Opin Obstet Gynecol. 2007 Oct;19(5):480-9
17885466
J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):615-20
18722974
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):245-51
18321633
J Gynecol Obstet Biol Reprod (Paris). 2004 Nov;33(7):577-88
15550876
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jun;19(6):787-93
18074068
Br J Urol. 1988 Jan;61(1):36-9
3342298